ADVANCED
PRECISION MEDICINE SOLUTION
MedTrait® Pharmacogenetic-Guided
Complete Medication Management Clinical Report
Trait Technologies, Inc. presents MedTrait® PGx-Guided Report for Medication Metabolism and Risk Factor Assessment.
MedTrait is a PGx-guided clinical report and interpretation solution which combines pharmacogenetics, drug interactions, duplicate therapy awareness, demographics and lifestyle factors into a powerful medication and risk information platform, offering healthcare providers a tool for personalized medicine, leading to better patient outcomes.
​
MedTrait bridges the gap between complicated genetic data and actionable clinical guidance, paving the way for better prescribing decisions - quickly and simply - in many areas of patient care including polypharmacy, pain management, mental health, cardiology, surgery, pediatrics, OB/GYN and more.
​
MedTrait is created by Trait Technologies, Inc. Our scientific leadership has over 26 years of genetic experience operating an industry-leading human DNA laboratory. The MedTrait team includes experienced professionals maintaining the most powerful pharmacogenetic interpretation and precision medicine bioinformatics software platform available.
Why MedTrait?
The MedTrait Advantage
Detailed Personalized Prescribing and Alternatives Guidance
Responsive, Interactive Real Time Decisions Platform
Actionable Clinical Reports
Jane Smith
ABOUT
​
STORY
MedTrait is a medication management and pharmacogenetic (PGx) interpretation reporting platform built by Trait Technologies, Inc. that allows clinicians to quickly evaluate current medications and help guide precision prescribing and treatment.
​
MedTrait launched in 2018.
​
MedTrait's scientific leadership first began offering clinical PGx testing in 2013. Over 25 years of genetic testing and interpretation experience has helped guide this unique group of scientists to find accurate and reliable solutions for personalized medicine.
VISION
MedTrait believes personalized medicine, guided by advances in genetics, helps bypass the traditional trial-and-error prescribing model to quickly reach optimal treatment. When performed and implemented properly, PGx testing significantly increases patient health outcomes and decreases inefficiencies within the healthcare system.
MedTrait is developed and designed to exceed these healthcare goals, with a high level of ethical scientific integrity and a focus on maximizing clinical utility.
TECHNOLOGY
MedTrait's curated interpretations, knowledge base and reporting platform are developed for transparent, quick and actionable prescribing guidance and risk factor assessment for whole-person treatment.
MedTrait comprehensively evaluates each person's genetics, drug-drug interactions, demographics and lifestyle factors to deliver treatment guidance for both current and future healthcare decisions and needs. The MedTrait report also includes access to the interactive MedTrait online app for updating medications, accessing updated scientific information and evaluating alternatives in real time.
​
MedTrait's whole-person approach targets multiple treatment areas including poly-pharmacy, mental health, pain management, cardiology, anti-ADHD, OB/GYN and surgery.
The flexibility of the MedTrait platform allows full implementation into existing systems as an interpretation solution, a full-featured standalone PGx-guided report, and everything in between.
MedTrait is backed by a team of professionals dedicated to delivering personalized medicine guidance with maximum transparency, clinical utility and accuracy. MedTrait is a collaborative effort of data curated by Trait Technology, Inc.’s genetic scientists and pharmacists with computer programmers to create a highly functional PGx-assisted medication management platform.
OUR
PARTNERS
